How does personalized medicine influence treatment for hyperactivity in ADHD?

PostedAugust 25, 2025

UpdatedSeptember 5, 2025

ByMy Patient Advice

Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

The rise of personalized medicine is transforming how we treat hyperactivity in ADHD. By considering individual genetics, lifestyle, and environment, clinicians can create custom plans that target the specific needs of each patient. This approach uses tools like genetic matching and detailed assessments to design tailored therapy, improving outcomes and reducing side effects.

Benefits of Personalized Medicine in ADHD

Here are some ways personalized medicine is shaping ADHD treatment:

Custom Plans Based on Genetics

Genetic testing can reveal how a person metabolises medication, helping doctors choose the most effective type and dosage for managing hyperactivity.

Tailored Therapy to Individual Needs

By taking emotional, behavioural, and social circumstances into account, treatment can be tailored to suit each person’s lifestyle and goals.

Fewer Side Effects

Matching medication and therapy to a patient’s genetic profile may reduce adverse reactions, making treatment more tolerable.

Dynamic Adjustments Over Time

Personalized medicine encourages ongoing monitoring, so plans can evolve as symptoms and circumstances change.

Improved Engagement and Outcomes

When patients feel their care is specifically designed for them, they are more likely to stick with treatment and see positive results.

By embracing personalized medicine, families and clinicians can create more effective custom plans through genetic matching and tailored therapy. Visit providers like ADHD Certify for personal consultations and advice on personalised approaches.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Hyperactivity.

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.